Quest Diagnostics Inc vs YieldMax AI & Tech Portfolio Option Income ETF — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.95B), while YieldMax AI & Tech Portfolio Option Income ETF trades at $43.6. The key difference: Quest Diagnostics Inc pays a 1.66% dividend while YieldMax AI & Tech Portfolio Option Income ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, YieldMax AI & Tech Portfolio Option Income ETF nearer its low. Which is the better fit depends on your goals.
| DGX | GPTY | |
|---|---|---|
Market Cap | $22.95B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $216.02 | $50.52 |
52-Week Low | $166.42 | $34.73 |
Enterprise Value | $28.97B | — |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.
Read more on GPTY →